MIAMI, March 22, 2018 -- Progressive Care Inc. (OTCQB: RXMD), a healthcare services and technology company, announces 2017 annual results.The Company announced over $20 million in net revenues, a 10% increase over 2016, and positive earnings of approximately $50,000. This represents the second consecutive year that the company has accomplished net positive earnings in its audited financial statements. Cost of goods sold increased relative to sales due to increases in DIR and other PBM fees implemented in 2017 as compared to 2016. Prescriptions filled increased 5% to over 225,000 during 2017. The company also filled over $2.7 million worth of prescriptions (Not Included in Net Revenues) for 340B entities during 2017, generating fees to the pharmacy of approximately $113,000, which is over a 400% increase over 2016.The annual report showcased the continued development of the Company’s portfolio of healthcare services. Noted within the Management Discussions are the key accomplishments of 2017 which include uplisting to OTCQB, the addition of independent board members, tele-pharmacy platform development, 12 non-resident state licenses and a 5 star pharmacy rating. The performance of the pharmacy has been recognized by Outcomes, the leading MTM platform, and Humana’s Quality Network for reaching performance metrics in key areas.The Company has declared ambitious plans during the 2018 fiscal year starting with the announcement of a planned acquisition of a pharmacy in Palm Beach County. In addition to year-over-year sales growth and profitability, the Company plans to expand into the development of proprietary products and technologies that will further diversify the Company’s healthcare service model. Though there are many risks disclosed in the annual report that stem from changes in the industry and government regulation to unforeseen market turndowns, the Company has a positive outlook on the coming year.“Filing our second year of audited financial statements 10 days early has a profound significance for me personally,” stated S. Parikh Mars, CEO. “In all the years, I have worked with Progressive Care both inside and out, we were not able to accomplish this goal until now. I could not be prouder of the accounting team we have put together this year and a staff that knows how to do things right every day. I hope that we are delivering the transparency our shareholders expect and the results that motivate them to keep believing in this company.”Get connected and stay in touch with us on social media:Progressive Care Inc.https://www.facebook.com/ProgressiveCareUS/https://twitter.com/ProgressCareUSPharmCo, LLChttps://www.facebook.com/pharmcorx/https://twitter.com/PharmCoRxAbout Progressive CareProgressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.Cautionary Statement Regarding Forward Looking StatementsStatements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company's actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.ContactArmen KarapetyanSenior Advisor Business Developmentarmen@progressivecareus.comwww.progressivecareus.comwww.pharmcopharmacy.com
Copyright 2022 © Progressive care inc.
Forward-looking Statements – This website contains forward-looking statements about our business. These forward-looking statements do not relate strictly to historical or current facts. Forward-looking statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “anticipate,” “estimate,” “plans,” “potential,” “projects,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend” or the negative of these words or other variations on these words or comparable terminology. You should not put undue reliance on these forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those reflected in such statements including: risks associated with current and potential future healthcare reforms; risks relating to technology failures or breaches; aspects of our business which are outside, risks relating to management and key personnel changes including attracting and retaining key personnel; failure to comply with legal and regulatory requirements; risks relating to access to capital and credit markets; risks related to indebtedness; exposure to claims and liabilities; changes in industry pricing benchmarks; and other risks and uncertainties that are described in the Risk Factors section of our recently filed Form 10-12G, including the presentation of financial statements and notes thereto, and other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov or by calling our Investor Relations department at (888) 919-7411 ext. 221. Forward-looking statements speak only as of the date they are posted to this website, unless an earlier date is indicated, and we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP FinancialMeasures–This presentationincludes certain “non-GAAP financial measures” as defined in Regulation G under the Securities Exchange Act of 1934. Schedules are attached that reconcile the non-GAAP financial measures included in this presentation to the most directly comparable financial measures calculatedand presentedin accordancewith Generally Accepted Accounting Principles in the United States. You should carefully read Progressive Care’s periodic and currentfilings on the OTCQB website for definitions and further explanation and disclosure regarding our use of non-GAAP financial measures and such filings should be read in conjunction with this presentation.
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!
.png){kind=logo}
